| Literature DB >> 27384178 |
Jan A C Hontelez1,2,3, Frank C Tanser1,4, Kevindra K Naidu1, Deenan Pillay1,5, Till Bärnighausen1,2.
Abstract
BACKGROUND: The effect of the rapid scale-up of vertical antiretroviral treatment (ART) programs for HIV in sub-Saharan Africa on the overall health system is under intense debate. Some have argued that these programs have reduced access for people suffering from diseases unrelated to HIV because ART programs have drained human and physical resources from other parts of the health system; others have claimed that the investments through ART programs have strengthened the general health system and the population health impacts of ART have freed up health care capacity for the treatment of diseases that are not related to HIV. To establish the population-level impact of ART programs on health care utilization in the public-sector health system, we compared trends in health care utilization among HIV-infected people receiving and not receiving ART with HIV-uninfected people during a period of rapid ART scale-up. METHODS ANDEntities:
Mesh:
Substances:
Year: 2016 PMID: 27384178 PMCID: PMC4934780 DOI: 10.1371/journal.pone.0158015
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Baseline characteristics of the participants.
| 2009 (n = 13,500) | 2010 (n = 14,472) | 2011 (n = 15,136) | 2012 (n = 14,713) | p-value | |
|---|---|---|---|---|---|
| Sex (%) | |||||
| Women | 9,588 (71.0%) | 9,618 (66.5%) | 9,969 (65.9%) | 9,595 (65.2%) | <0.001 |
| Men | 3,912 (29.0%) | 4,854 (33.5%) | 5,164 (34.1%) | 5,118 (34.8%) | |
| Median age [IQR] | 30 [21; 49] | 30 [20; 50] | 31 [20; 51] | 30 [19; 51] | 0.8 |
| HIV and ART status | |||||
| HIV- | 7,760 (56.8%) | 9,171 (63.4%) | 9,014 (59.6%) | 7,422 (50.5%) | <0.001 |
| HIV+, not on ART | 1,706 (12.6%) | 2,051 (14.2%) | 1,934 (12.8%) | 1,600 (10.9%) | |
| HIV+, on ART | 635 (4.7%) | 854 (5.9%) | 1,068 (7.1%) | 1,336 (9.1%) | |
| HIV status unknown | 3,489 (25.8%) | 2,396 (16.6%) | 3,120 (20.6%) | 4,355 (29.6%) | |
| | 27.2% (25.4%; 29.0%) | 29.4% (27.7%; 31.1%) | 35.6% (33.9%; 37.3%) | 45.5% (43.7%; 47.3%) | <0.001 |
| Clinic visit in last 6 m (%) | |||||
| Yes | 5,819 (43.6%) | 6,851 (47.3%) | 7,759 (51.3%) | 7,300 (49.6%) | <0.001 |
| No | 6,903 (51.1%) | 7,586 (52.4%) | 7,341 (48.5%) | 7,379 (50.2%) | |
| Missing | 706 (5.2%) | 35 (0.2%) | 36 (0.2%) | 34 (0.2%) | |
| Hospitalization rate per 1000 PY (95% CI) | 87.3 (78.4; 96.1) | 62.6 (57.8; 67.4) | 61.4 (56.8; 65.9) | 45.9 (41.7; 50.2) | <0.001 |
| Area of residence | |||||
| Rural | 7,996 (60.0%) | 8,485 (58.9%) | 8,882 (58.9%) | 8,572 (58.3%) | <0.001 |
| Peri-urban | 3,392 (25.5%) | 4,409 (30.6%) | 4,580 (30.4%) | 5,126 (35.9%) | |
| Urban | 595 (4.5%) | 704 (4.9%) | 773 (5.1%) | 933 (6.3%) | |
| Outside DSA | 1,340 (10.1%) | 808 (5.6%) | 855 (5.7%) | 74 (0.5%) |
Fig 1Trend in age-standardized self-reported health care utilization by HIV status over the years 2009 to 2012 in rural KwaZulu-Natal, South Africa.
A. Proportion of people reporting to have visited a public-sector PHC clinic in the last 6 months. B. Proportion of people reporting to have visited a private-sector PHC clinic in the last 6 months. C. Self-reported hospitalization rates over the last 12 months. The public-sector ART program started in 2004. Pre-2009 trend in ART coverage was as follows: 0.0% in 2004; 1.0% in 2005; 3.8% in 2006; 8.3% in 2007; 14.3% in 2008 [26]. Coverage in the study period was as follows: 27.2% in 2009; 29.4% in 2010; 35.6% in 2011; and 45.5% in 2012 (Table 1).
Multivariable regressions of health care utilization on HIV status, ART status, duration on ART, and calendar year.
| Parameter | Public-sector PHC clinic visits | Private-sector PHC clinic visits | Hospitalization rate | |||
|---|---|---|---|---|---|---|
| AOR (95% CI) | p-value | AOR (95% CI) | p-value | AIRR (95% CI) | p-value | |
| HIV - | ||||||
| 2009 | 1 | - | 1 | - | 1 | - |
| 2010 | 1.06 (0.99; 1.12) | 0.085 | 0.80 (0.74; 0.87) | <0.001 | 0.70 (0.59; 0.83) | <0.001 |
| 2011 | 1.28 (1.20; 1.36) | <0.001 | 0.72 (0.66; 0.78) | <0.001 | 0.68 (0.58; 0.81) | <0.001 |
| 2012 | 1.24 (1.16; 1.32) | <0.001 | 0.52 (0.47; 0.57) | <0.001 | 0.52 (0.43; 0.64) | <0.001 |
| HIV +, no ART | ||||||
| 2009 | 1.30 (1.16; 1.46) | <0.001 | 1.24 (1.08; 1.42) | 0.002 | 1.30 (0.99; 1.72) | 0.062 |
| 2010 | 1.49 (1.34; 1.65) | <0.001 | 1.01 (0.88; 1.15) | 0.918 | 1.01 (0.81; 1.27) | 0.918 |
| 2011 | 1.71 (1.53; 1.91) | <0.001 | 0.90 (0.78; 1.03) | 0.121 | 0.85 (0.69; 1.06) | 0.152 |
| 2012 | 1.69 (1.50; 1.90) | <0.001 | 0.66 (0.56; 0.78) | <0.001 | 0.76 (0.58; 0.99) | 0.041 |
| On ART ≤6m | ||||||
| 2009 | 4.96 (2.94; 8.37) | <0.001 | 2.15 (1.41; 3.30) | <0.001 | 1.80 (1.35; 4.85) | 0.041 |
| 2010 | 6.55 (3.80; 11.30) | <0.001 | 1.48 (0.94; 2.32) | 0.092 | 2.56 (1.35; 4.85) | 0.004 |
| 2011 | 11.53 (5.97; 22.27) | <0.001 | 1.85 (1.22; 2.82) | 0.004 | 2.18 (1.37; 3.46) | 0.001 |
| 2012 | 5.30 (3.24; 8.66) | <0.001 | 0.93 (0.58; 1.49) | 0.766 | 1.78 (1.07; 2.95) | 0.025 |
| On ART > 6m | ||||||
| 2009 | 3.86 (3.07; 4.87) | <0.001 | 1.31 (1.06; 1.62) | 0.013 | 2.67 (1.80; 3.94) | <0.001 |
| 2010 | 4.81 (3.91; 5.92) | <0.001 | 0.89 (0.73; 1.09) | 0.257 | 1.27 (0.94; 1.71) | 0.120 |
| 2011 | 7.26 (5.90; 8.94) | <0.001 | 0.80 (0.67; 0.96) | 0.019 | 1.44 (1.09; 1.91) | 0.009 |
| 2012 | 3.66 (3.14; 4.27) | <0.001 | 0.58 (0.48; 0.69) | <0.001 | 0.88 (0.66; 1.15) | 0.401 |
| HIV status unknown | ||||||
| 2009 | 0.82 (0.74; 0.90) | <0.001 | 1.25 (1.12; 1.40) | <0.001 | 0.88 (0.68; 1.15) | 0.346 |
| 2010 | 0.86 (0.78; 0.95) | 0.005 | 1.12 (0.98; 1.28) | 0.099 | 0.60 (0.47; 0.78) | <0.001 |
| 2011 | 0.96 (0.88; 1.05) | 0.413 | 1.01 (0.90; 1.14) | 0.840 | 0.64 (0.51; 0.81) | <0.001 |
| 2012 | 0.90 (0.83; 0.98) | 0.014 | 0.70 (0.62; 0.79) | <0.001 | 0.41 (0.33; 0.52) | <0.001 |
| Sex | ||||||
| Female | 1 | - | 1 | - | 1 | - |
| Male | 0.46 (0.44; 0.48) | <0.001 | 0.62 (0.59; 0.66) | <0.001 | 0.85 (0.77; 0.94) | 0.002 |
| Age (continuous, per year) | 1.09 (1.09; 1.10) | <0.001 | 1.08 (1.08; 1.09) | <0.001 | 1.03 (1.01; 1.04) | <0.001 |
| Age2 | 0.99 (0.99; 0.99) | <0.001 | 0.99 (0.99; 0.99) | <0.001 | 0.99 (0.99; 0.99) | <0.001 |
| Area of living | ||||||
| Rural | 1 | - | 1 | - | 1 | - |
| Peri-urban | 0.94 (0.90; 0.98) | 0.009 | 1.18 (1.11; 1.25) | <0.001 | 1.16 (1.04; 1.28) | 0.007 |
| Urban | 0.79 (0.72; 0.87) | <0.001 | 2.06 (1.85; 2.29) | <0.001 | 1.51 (1.28; 1.78) | <0.001 |
| Outside DSA | 0.48 (0.44; 0.53) | <0.001 | 1.48 (1.31; 1.66) | <0.001 | 0.78 (0.62; 0.96) | 0.019 |
| | 56818 | 56300 | 57524 | |||
| AIC | 68363 | 43827 | 28286 | |||
| BIC | 68595 | 44059 | 28519 | |||
| DF | 26 | 26 | 26 | |||
| Log likelihood | -34155 | -21887 | -14117 | |||
| p-value | <0.001 | <0.001 | <0.001 | |||
PHC = primary health care, AOR = Adjusted Odds Ratio, AIRR = Adjusted Incidence Rate Ratio, N = Number of observations, AIC = Akaike Information Criterion, BIC = Bayesian Information Criterion, DF = Degrees of Freedom, DSA = Demographic Surveillance Area
Logistic regressions for public- and private-sector PHC clinics; Poisson regressions for hospitalization rates.
Models with trends in utilization over time by HIV status, ART status, and calendar year, corrected for sex, age, and area of residence are shown. Both uncorrected and corrected trends are given in S1 Table. All regression models contain random individual effects. Pre-2009 trend in ART coverage was as follows: 0.0% in 2004; 1.0% in 2005; 3.8% in 2006; 8.3% in 2007; 14.3% in 2008 [25]. Coverage in the study period was as follows: 27.2% in 2009; 29.4% in 2010; 35.6% in 2011; and 45.5% in 2012 (Table 1).